BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27542090)

  • 21. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner?
    Tohidinezhad F; Eslami S; Abu-Hanna A; Aliakbarian M
    Exp Clin Transplant; 2018 Dec; 16(6):721-729. PubMed ID: 29457445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?
    Finkenstedt A; Dorn L; Edlinger M; Prokop W; Risch L; Griesmacher A; Graziadei I; Vogel W; Zoller H
    Liver Int; 2012 Sep; 32(8):1211-6. PubMed ID: 22380485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone changes in patients with liver cirrhosis before and after orthotopic liver transplantation and its correlation with MELD.
    Nitsche R; Coelho JC; Freitas AC; Zeni Neto C; Martins E
    Arq Gastroenterol; 2014; 51(1):59-63. PubMed ID: 24760066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Region 11 MELD Na exception prospective study.
    Fisher RA; Heuman DM; Harper AM; Behnke MK; Smith AD; Russo MW; Zacks S; McGillicuddy JW; Eason J; Porayko MK; Northup P; Marvin MR; Hundley J; Nair S
    Ann Hepatol; 2012; 11(1):62-7. PubMed ID: 22166562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
    Kuo SZ; Ahmad M; Dunn MA; Montano-Loza AJ; Carey EJ; Lin S; Moghe A; Chen HW; Ebadi M; Lai JC
    Transplantation; 2019 Nov; 103(11):2312-2317. PubMed ID: 30985575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
    Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V;
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
    J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation.
    Stravitz RT; Reuben A; Mizrahi M; Lalazar G; Brown K; Gordon SC; Ilan Y; Sanyal A
    J Hepatol; 2015 Dec; 63(6):1345-51. PubMed ID: 26220750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    O'Leary JG; Wong F; Reddy KR; Garcia-Tsao G; Kamath PS; Biggins SW; Fallon MB; Subramanian RM; Maliakkal B; Thacker L; Bajaj JS
    Dig Dis Sci; 2017 Mar; 62(3):768-776. PubMed ID: 28025746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis.
    Wei Q; Nemdharry RS; Zhuang RZ; Li J; Ling Q; Wu J; Shen T; Zhou L; Xie HY; Zhang M; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):164-168. PubMed ID: 28381380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
    Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
    Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Toussaint A; Weiss E; Khoy-Ear L; Janny S; Cohen J; Delefosse D; Guillemet L; Gayat E; Paugam-Burtz C
    Transplantation; 2016 Apr; 100(4):819-24. PubMed ID: 26845306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
    Lai JC; Ganger DR; Volk ML; Dodge JL; Dunn MA; Duarte-Rojo A; Kappus MR; Rahimi RS; Ladner DP; Boyarsky B; McAdams-DeMarco M; Segev DL; McCulloch CE; Verna EC
    JAMA Surg; 2021 Mar; 156(3):256-262. PubMed ID: 33377947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.